G0701632/MRC_/Medical Research Council/United Kingdom[Grants and Funding] - Search Results

Year	Number of Results
2011	1
2012	3
2013	2
2014	5
2015	2
2016	4
2017	3
2020	3
2021	3
2022	1
2023	2
2024	0

1

Husebye ES, Pearce SH, Krone NP, Kämpe O. Husebye ES, et al. Lancet. 2021 Feb 13;397(10274):613-629. doi: 10.1016/S0140-6736(21)00136-7. Epub 2021 Jan 20. Lancet. 2021. PMID: 33484633 Review.

2

Adrenal insufficiency - recognition and management.

Pazderska A, Pearce SH. Pazderska A, et al. Clin Med (Lond). 2017 Jun;17(3):258-262. doi: 10.7861/clinmedicine.17-3-258. Clin Med (Lond). 2017. PMID: 28572228 Free PMC article. Review.

3

Current and emerging therapies for Addison's disease.

Napier C, Pearce SH. Napier C, et al. Curr Opin Endocrinol Diabetes Obes. 2014 Jun;21(3):147-53. doi: 10.1097/MED.0000000000000067. Curr Opin Endocrinol Diabetes Obes. 2014. PMID: 24755997 Review.

4

Autoimmune Addison disease: pathophysiology and genetic complexity.

Mitchell AL, Pearce SH. Mitchell AL, et al. Nat Rev Endocrinol. 2012 Jan 31;8(5):306-16. doi: 10.1038/nrendo.2011.245. Nat Rev Endocrinol. 2012. PMID: 22290360 Review.

5

Impact of Month of Birth on the Risk of Development of Autoimmune Addison's Disease.

Pazderska A, Fichna M, Mitchell AL, Napier CM, Gan E, Ruchała M, Santibanez-Koref M, Pearce SH. Pazderska A, et al. J Clin Endocrinol Metab. 2016 Nov;101(11):4214-4218. doi: 10.1210/jc.2016-2392. Epub 2016 Aug 30. J Clin Endocrinol Metab. 2016. PMID: 27575942 Free PMC article.

6

MANAGEMENT OF ENDOCRINE DISEASE: Regenerative therapies in autoimmune Addison's disease.

Gan EH, Pearce SH. Gan EH, et al. Eur J Endocrinol. 2017 Mar;176(3):R123-R135. doi: 10.1530/EJE-16-0581. Epub 2016 Nov 3. Eur J Endocrinol. 2017. PMID: 27810905 Review.

7

MANAGEMENT OF ENDOCRINE DISEASE: Residual adrenal function in Addison's disease.

Pearce SHS, Gan EH, Napier C. Pearce SHS, et al. Eur J Endocrinol. 2021 Feb;184(2):R61-R67. doi: 10.1530/EJE-20-0894. Eur J Endocrinol. 2021. PMID: 33306039 Free PMC article. Review.

8

Vitamin D status and pathway genes in five European autoimmune Addison's disease cohorts.

Penna-Martinez M, Meyer G, Wolff AB, Skinningsrud B, Betterle C, Falorni A, Ollier W, Undlien D, Husebye E, Pearce S, Mitchell AL, Badenhoop K. Penna-Martinez M, et al. Eur J Endocrinol. 2021 Mar;184(3):373-381. doi: 10.1530/EJE-20-0956. Eur J Endocrinol. 2021. PMID: 33444227

9

AIRE is not essential for the induction of human tolerogenic dendritic cells.

Crossland KL, Abinun M, Arkwright PD, Cheetham TD, Pearce SH, Hilkens CM, Lilic D. Crossland KL, et al. Autoimmunity. 2016 Jun;49(4):211-8. doi: 10.3109/08916934.2016.1148692. Epub 2016 Feb 25. Autoimmunity. 2016. PMID: 26912174

10

Heterogeneous natural history of Addison's disease: mineralocorticoid deficiency may predominate.

Howarth S, Giovanelli L, Napier C, Pearce SH. Howarth S, et al. Endocr Connect. 2022 Dec 15;12(1):e220305. doi: 10.1530/EC-22-0305. Print 2023 Jan 1. Endocr Connect. 2022. PMID: 36398876 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

26 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year